Phreesia, Inc. (NYSE:PHR) Receives Consensus Recommendation of "Buy" from Analysts

Phreesia, Inc. (NYSE:PHR - Get Free Report) has earned an average rating of "Buy" from the thirteen analysts that are covering the firm, MarketBeat.com reports. Thirteen investment analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have issued a report on the stock in the last year is $31.15.

A number of research analysts have recently weighed in on PHR shares. Royal Bank of Canada raised Phreesia from a "sector perform" rating to an "outperform" rating and increased their price objective for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Needham & Company LLC reissued a "buy" rating and issued a $29.00 price objective on shares of Phreesia in a report on Friday, January 10th. Truist Financial increased their price objective on Phreesia from $31.00 to $34.00 and gave the company a "buy" rating in a report on Wednesday, December 11th. Piper Sandler reissued an "overweight" rating and issued a $33.00 price objective (up from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Finally, JMP Securities reissued a "market outperform" rating and issued a $30.00 price objective on shares of Phreesia in a report on Tuesday, December 10th.

Insider Buying and Selling at Phreesia

In other Phreesia news, SVP Amy Beth Vanduyn sold 1,311 shares of the firm's stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $34,885.71. Following the sale, the senior vice president now directly owns 115,633 shares of the company's stock, valued at approximately $3,076,994.13. This trade represents a 1.12 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michael Weintraub sold 15,152 shares of the firm's stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $21.01, for a total value of $318,343.52. Following the completion of the sale, the director now directly owns 242,827 shares in the company, valued at approximately $5,101,795.27. The trade was a 5.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 167,173 shares of company stock valued at $4,221,400. Company insiders own 5.80% of the company's stock.

Hedge Funds Weigh In On Phreesia

Several hedge funds and other institutional investors have recently made changes to their positions in PHR. R Squared Ltd purchased a new position in shares of Phreesia in the fourth quarter valued at approximately $30,000. International Assets Investment Management LLC lifted its position in Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company's stock worth $33,000 after buying an additional 1,395 shares in the last quarter. BankPlus Trust Department purchased a new position in Phreesia during the fourth quarter worth approximately $34,000. Venturi Wealth Management LLC purchased a new position in Phreesia during the fourth quarter worth approximately $76,000. Finally, Smartleaf Asset Management LLC lifted its position in Phreesia by 154.6% during the fourth quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company's stock worth $89,000 after buying an additional 2,090 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company's stock.

Phreesia Stock Up 5.4 %

Phreesia stock traded up $1.55 during midday trading on Monday, reaching $29.98. The company's stock had a trading volume of 822,685 shares, compared to its average volume of 377,775. The stock's 50-day simple moving average is $26.43 and its 200-day simple moving average is $23.59. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. Phreesia has a 52-week low of $17.07 and a 52-week high of $30.02. The stock has a market capitalization of $1.74 billion, a P/E ratio of -20.39 and a beta of 0.96.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.04. The company had revenue of $106.80 million during the quarter, compared to analysts' expectations of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm's revenue was up 16.6% compared to the same quarter last year. During the same period last year, the business posted ($0.58) earnings per share. On average, sell-side analysts expect that Phreesia will post -1.1 EPS for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.